Reuters logo
2 years ago
BRIEF-ViiV Healthcare announces positive results from a study of two drug injectable regimen
November 3, 2015 / 12:12 PM / 2 years ago

BRIEF-ViiV Healthcare announces positive results from a study of two drug injectable regimen

Nov 3 (Reuters) - GlaxoSmithKline Plc

* ViiV healthcare announces positive headline results from a study of two drug injectable regimen for HIV maintenance therapy

* Two patients met protocol defined Virologic failure criteria, Q8W (N=1), Oral (N=1); neither patient had evidence of resistance at failure. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below